ALTSHULER DAVID 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Mar 12, 2025
Insider Transaction Report
Form 4
ALTSHULER DAVID
EVP, Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-03-10$500.00/sh−3,231$1,615,500→ 26,512 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024.